Discover
CORZ
Core Scientific, Inc.
13.53
7 x 10.30
10 x 17.39
bid
ask
-
0.93
6.43%
02:08 PM
timesize
| Ytd | -7.11% | |
| 1y | -31.24% |
13.50
day range
14.51
13.51
52 week range
29.16
| Open | 14.05 | Prev Close | 14.46 | Low | 13.50 | High | 14.51 | Mkt Cap | 4.35B |
| Vol | 13.38M | Avg Vol | 12.76M | EPS | -3.72 | P/E | N/A | Forward P/E | 88.81 |
| Beta | 5.49 | Short Ratio | 5.85 | Inst. Own | 120.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 17.51 | 200-d Avg | 19.80 | 1yr Est | 33.05 |
| Income Statement | |||
| Total Revenue | 164.20M | ||
| Revenues (USD) | 164.20M | ||
| Cost of Revenue | 94.16M | ||
| Gross Profit | 70.04M | ||
| Operating Expenses | 148.51M | ||
| Selling, General and Administrative Expense | 49.39M | ||
| Operating Income | -78.47M | ||
| Interest Expense | 23.83M | ||
| Income Tax Expense | 1.91M | ||
| Net Income | -1.16B | ||
| Net Income Common Stock | -1.16B | ||
| Net Income Common Stock (USD) | -1.16B | ||
| Consolidated Income | -1.16B | ||
| Earnings per Basic Share | -3.32 | ||
| Earnings per Basic Share (USD) | -3.32 | ||
| Earnings per Diluted Share | -3.32 | ||
| Earning Before Interest & Taxes (EBIT) | -1.13B | ||
| Earning Before Interest & Taxes (USD) | -1.13B | ||
| Weighted Average Shares | 325.33M | ||
| Weighted Average Shares Diluted | 325.33M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.94B | ||
| Cash and Equivalents (USD) | 1.94B | ||
| Investments | 665.59M | ||
| Investments Current | 49.68M | ||
| Investments Non-Current | 615.91M | ||
| Trade and Non-Trade Receivables | 458.49M | ||
| Current Assets | 2.44B | ||
| Property, Plant & Equipment Net | 1.89B | ||
| Total Assets | 5.26B | ||
| Total Debt | 4.30B | ||
| Current Liabilities | 2.74B | ||
| Debt Non-Current | 4.30B | ||
| Total Liabilities | 7.68B | ||
| Accumulated Retained Earnings (Deficit) | -5.65B | ||
| Shareholders Equity | -2.42B | ||
| Shareholders Equity (USD) | -2.42B | ||
| Assets Non-Current | 2.81B | ||
| Total Debt (USD) | 4.30B | ||
| Deferred Revenue | 654.44M | ||
| Goodwill and Intangible Assets | 228.63M | ||
| Liabilities Non-Current | 4.94B | ||
| Trade and Non-Trade Payables | 112.37M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 15.50M | ||
| Net Cash Flow from Financing | 2.22B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.41B | ||
| Capital Expenditure | -796.22M | ||
| Issuance (Purchase) of Equity Shares | -81.00K | ||
| Issuance (Repayment) of Debt Securities | 2.23B | ||
| Net Cash Flow from Investing | -796.24M | ||
| Net Cash Flow from Operations | -18.93M | ||
| Share Based Compensation | 18.24M | ||